Regimmune Corporation
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation (NCT04014790) | Regimmune Corporation | 2019-11-25 |
| Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) (NCT01379209) | Regimmune Corporation | 2011-09-01 |
Track Regimmune Corporation automatically
Every clearance here is in the API, with alerts when new ones post.